Lennox International Inc. designs, manufactures, and markets a range of products for the heating, ventilation, air conditioning, and refrigeration markets in the United States, Europe, the Asia Pacific, South America, and Canada. The company has market cap of $8.27 billion. The firm operates in three divisions: Residential Heating & Cooling, Commercial Heating & Cooling, and Refrigeration. It has a 27.75 P/E ratio. The Residential Heating & Cooling segment provides furnaces, air conditioners, heat pumps, packaged heating and cooling systems, indoor air quality equipment, comfort control products, and replacement parts and supplies for residential replacement and new construction markets.
Avenue Therapeutics, Inc. (ATXI) formed wedge down with $3.42 target or 9.00% below today’s $3.76 share price. Avenue Therapeutics, Inc. (ATXI) has $38.60 million valuation. The stock increased 2.45% or $0.09 during the last trading session, reaching $3.76. About 28,446 shares traded. Avenue Therapeutics, Inc. (NASDAQ:ATXI) has 0.00% since February 12, 2017 and is . It has underperformed by 16.70% the S&P500.
Since January 1, 0001, it had 0 insider buys, and 9 selling transactions for $7.15 million activity.
The stock increased 2.60% or $5.02 during the last trading session, reaching $198.06. About 577,629 shares traded or 103.71% up from the average. Lennox International Inc. (LII) has risen 31.87% since February 12, 2017 and is uptrending. It has outperformed by 15.17% the S&P500.
Rk Capital Management Llc holds 2.91% of its portfolio in Lennox International Inc. for 69,800 shares. Horrell Capital Management Inc. owns 28,070 shares or 2.78% of their US portfolio. Moreover, Stone Run Capital Llc has 2.35% invested in the company for 25,500 shares. The New York-based Hilton Capital Management Llc has invested 1.94% in the stock. Atlanta Capital Management Co L L C, a Georgia-based fund reported 1.46 million shares.